The distribution of the PAM50 intrinsic subtype classification differed between primary (Figures 4A, C) and metastatic tumors (Figures 4B, D): HER2-Enriched subtype was significantly more frequent in the metastatic tissue (22% vs. 7%; p=0.005). Here, ERBB2 is linked to metastatic neoplasm.